Civriz, A. H. Et Al. 2023. The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment. Urologic Oncology: Seminars and Original Investigations , vol.41, no.12 .

Civriz, A. H., Teke, K., Akdaş, E. M., Dillioğlugil, Ö., Vural, Ç., & Yaprak Bayrak, B., (2023). The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment. Urologic Oncology: Seminars and Original Investigations , vol.41, no.12.

Civriz, AZİZ Et Al. "The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment," Urologic Oncology: Seminars and Original Investigations , vol.41, no.12, 2023

Civriz, AZİZ H. Et Al. "The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment." Urologic Oncology: Seminars and Original Investigations , vol.41, no.12, 2023

Civriz, A. H. Et Al. (2023) . "The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment." Urologic Oncology: Seminars and Original Investigations , vol.41, no.12.

@article{article, author={AZİZ HAKKI CİVRİZ Et Al. }, title={The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta/T1 urothelial carcinoma before and after BCG treatment}, journal={Urologic Oncology: Seminars and Original Investigations}, year=2023}